NCT02965495View on ClinicalTrials.gov

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Osteoarthritis, Knee
Interventions
DRUG

YYD302 2ml

YYD302 2ml

DRUG

YYD302 3ml

YYD302 3ml

DRUG

Placebo 3ml

phosphate buffered saline 3ml

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT02965495 - Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter